We are live on ! Find out more
KZIA

Kazia Therapeutics
KZIA

15 hedge funds and large institutions have $1.67M invested in Kazia Therapeutics in 2015 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

86% more capital invested

Capital invested by funds: $897K → $1.67M (+$772K)

67% more funds holding

Funds holding: 9 → 15 (+6)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
15
Holders Change
+6
Holders Change %
+66.67%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
2
Reduced
3
Closed
3
Calls
$60K
Puts
–
Net Calls
+$60K
Net Calls Change
+$60K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$638K
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$340K
3
VKH
Virtu KCG Holdings
New York
+$184K
4
Goldman Sachs
Goldman Sachs
New York
+$138K
5
Millennium Management
Millennium Management
New York
+$128K

Top Sellers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$172K
2
CS
Credit Suisse
Switzerland
-$92K
3
Jane Street
Jane Street
New York
-$77.2K
4
UBS Group
UBS Group
Switzerland
-$52.2K
5
Citigroup
Citigroup
New York
-$4.54K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$867K +$638K +562 +109%
Hudson Bay Capital Management
2
Hudson Bay Capital Management
Connecticut
$241K +$340K +300 New
VKH
3
Virtu KCG Holdings
New York
$130K +$184K +162 New
Goldman Sachs
4
Goldman Sachs
New York
$98K +$138K +122 New
Millennium Management
5
Millennium Management
New York
$91K +$128K +113 New
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$56K +$79.4K +70 New
Citadel Advisors
7
Citadel Advisors
Florida
$49K +$69.2K +61 New
Jane Street
8
Jane Street
New York
$44K -$77.2K -68 -56%
TRCT
9
Tower Research Capital (TRC)
New York
$42K +$59K +52 New
Bank of America
10
Bank of America
North Carolina
$16K – – –
Morgan Stanley
11
Morgan Stanley
New York
$12K +$1.14K +1 +7%
MWP
12
MYCIO Wealth Partners
Pennsylvania
$8K +$11.3K +10 New
Citigroup
13
Citigroup
New York
$7K -$4.54K -4 -31%
Canada Life
14
Canada Life
Manitoba, Canada
$5K +$6.81K +6 New
UBS Group
15
UBS Group
Switzerland
$3K -$52.2K -46 -92%
Bank of Montreal
16
Bank of Montreal
Ontario, Canada
– -$172K -200 Closed
CS
17
Credit Suisse
Switzerland
– -$92K -107 Closed
Creative Planning
18
Creative Planning
Kansas
– -$1K -1 Closed

KZIA Hedge Fund Activity: Q2 2015 in Review

15 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q2 2015, worth a combined $1.67M — up 86% from $897K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new KZIA positions and 3 closed out — a net gain of 6 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $638K. The largest seller was Bank of Montreal, exiting entirely with an estimated $172K sold.

  • 15 institutional investors held Kazia Therapeutics (KZIA) as of Q2 2015, up from 9 in Q1 2015.
  • Funds reported $1.67M of Kazia Therapeutics stock for Q2 2015, up 86% quarter-over-quarter.
  • 9 funds opened new Kazia Therapeutics positions in Q2 2015 and 3 closed out, a net change of +6 holders.
  • The largest Kazia Therapeutics buyer in Q2 2015 was Renaissance Technologies, an estimated $638K added.
  • The largest Kazia Therapeutics seller in Q2 2015 was Bank of Montreal, an estimated $172K sold.

Based on aggregated 13F filings for Q2 2015.